164
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Early management of COPD: where are we now and where do we go from here? A Delphi consensus project

, , , , , , , , , , , , & show all
Pages 353-360 | Published online: 04 Feb 2019

Figures & data

Figure 1 Level of consensus on the early management of COPD.

Abbreviations: GP, general practitioner; IPRAS, Inter-percentile Range Adjusted for Symmetry.
Figure 1 Level of consensus on the early management of COPD.

Figure 2 Relevance of factors limiting early diagnosis of COPD according to expert panel.

Note: First, second, third, and fourth refer to the rank order of the answers.
Abbreviation: GP, general practitioner.
Figure 2 Relevance of factors limiting early diagnosis of COPD according to expert panel.

Figure 3 Level of confidence in different approaches used in the early management of COPD to reduce the functional decline.

Note: Each pairwise comparison was significant (P<0.001).

Abbreviations: ICS, inhaled corticosteroid; LABA, long-acting beta-agonist; LAMA, long-acting muscarinic antagonist.

Figure 3 Level of confidence in different approaches used in the early management of COPD to reduce the functional decline.Note: Each pairwise comparison was significant (P<0.001).Abbreviations: ICS, inhaled corticosteroid; LABA, long-acting beta-agonist; LAMA, long-acting muscarinic antagonist.

Figure 4 Level of consensus on different treatments in patients younger and older with moderate obstruction (mean ± 95% CI).

Abbreviations: ICS, inhaled corticosteroid; LABA, long-acting beta-agonist; LAMA, long-acting muscarinic antagonist.
Figure 4 Level of consensus on different treatments in patients younger and older with moderate obstruction (mean ± 95% CI).